Floatz logo

Entinostat

Recurrent Adult Lymphoblastic Lymphoma

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

84 Active assets in the Recurrent Adult Lymphoblastic Lymphoma cohort.

Asset / SponsorPhaseRating
Cladribine
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 4BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University of Washington
Phase 4BBB
ASPARAGINASE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 4BBB
MERCAPTOPURINE ANHYDROUS
City of Hope Medical Center
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB

View all 50 →

Same molecule, other indications

Entinostat is also rated in:

Stage IIIA Non-Small Cell Lung CancerDormant
BB
Indicative ·
69 / 100
View asset →
triple-negative breast carcinomaDormant
B
Indicative ·
63 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →